Lobbying Income
$24.6M
Filings
840
Unique Clients
17
Active Period
2010–2026
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Promoting Innovation in Blockchain Development Act
2026 · third_quarter · Client: DEFI EUDCATION FUND
Issues related AML and decentralized blockchains; HR 7732
Client expense: — · Firm income: $30,000
Matched citations: HR 7732
General lobbying on issues related to payments and financial services; issues relating to the Credit Card Competition Act; analysis of policy landscape for competition issues generally; monitor crypto market structure vote in the Senate; S.1838/H.R.3881, the Credit Card Competition Act of 2026 and possible chnages to NDAA as well as amendments to the Clarity Act
Client expense: — · Firm income: $30,000
Matched citations: H.R.3881
DeOndra Dixon INCLUDE Project Act of 2026
2026 · third_quarter · Client: VISA, INC.
General lobbying on issues related to payments and financial services; issues relating to the Credit Card Competition Act; analysis of policy landscape for competition issues generally; monitor crypto market structure vote in the Senate; S.1838/H.R.3881, the Credit Card Competition Act of 2026 and possible chnages to NDAA as well as amendments to the Clarity Act
Client expense: — · Firm income: $30,000
Matched citations: S.1838
Combating Organized Retail Crime Act of 2025
2026 · third_quarter · Client: INTERNATIONAL COUNCIL OF SHOPPING CENTERS
S 1404, CORCA; HR 2853 and NDAA
Client expense: — · Firm income: $30,000
Matched citations: HR 2853
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
2026 · third_quarter · Client: INTERNATIONAL COUNCIL OF SHOPPING CENTERS
Monitor efforts to revive Subchapter V of the Bankruptcy Code; HR 5371
Client expense: — · Firm income: $30,000
Matched citations: HR 5371
Combating Organized Retail Crime Act
2026 · third_quarter · Client: INTERNATIONAL COUNCIL OF SHOPPING CENTERS
S 1404, CORCA; HR 2853 and NDAA
Client expense: — · Firm income: $30,000
Matched citations: S 1404
To designate the Pride flag as an authorized flag eligible for display at units of the National Park System, to express the sense of Congress that the Pride flag should be on display at the Stonewall National Monument in the State of New York, and for other purposes.
2026 · third_quarter · Client: TAXPAYERS AGAINST FRAUD
Advocate for end to double taxation of whistleblower awards; IRS reform, HR 7659
Client expense: — · Firm income: $60,000
Matched citations: HR 7659
ROCR Value Based Program Act
2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2120
Promoting Resilient Supply Chains Act of 2025
2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
H.R. 2444, Promoting Resilient Supply Chains Act; S. 257, Promoting Resilient Supply Chains
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2444
Seniors’ Access to Critical Medications Act of 2025
2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2484
Ensuring Community Access to Pharmacist Services Act
2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S. 2426, Equitable Community Access to Pharmacist Services Act. Issues related to support for independent physician practices, community pharmacies, and community-based care.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3164
Ensuring Community Access to Pharmacist Services Act
2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
H.R. 3521, Clinical Trial Modernization Act; Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases). Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S. 2426, Equitable Community Access to Pharmacist Services Act. Issues related to support for independent physician practices, community pharmacies, and community-based care.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3164
Improving Seniors’ Timely Access to Care Act of 2025
2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3514
Clinical Trial Modernization Act
2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
H.R. 3521, Clinical Trial Modernization Act; Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases). Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S. 2426, Equitable Community Access to Pharmacist Services Act. Issues related to support for independent physician practices, community pharmacies, and community-based care.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3521
Protecting Patient Access to Cancer and Complex Therapies Act
2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 4299
Medicare Patient Access and Practice Stabilization Act of 2025
2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 879
Improving Seniors’ Timely Access to Care Act of 2025
2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness.
Client expense: — · Firm income: $30,000
Matched citations: S. 1816
Equitable Community Access to Pharmacist Services Act
2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S. 2426, Equitable Community Access to Pharmacist Services Act. Issues related to support for independent physician practices, community pharmacies, and community-based care.
Client expense: — · Firm income: $30,000
Matched citations: S. 2426
Equitable Community Access to Pharmacist Services Act
2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
H.R. 3521, Clinical Trial Modernization Act; Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases). Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S. 2426, Equitable Community Access to Pharmacist Services Act. Issues related to support for independent physician practices, community pharmacies, and community-based care.
Client expense: — · Firm income: $30,000
Matched citations: S. 2426
Promoting Resilient Supply Chains Act of 2025
2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
H.R. 2444, Promoting Resilient Supply Chains Act; S. 257, Promoting Resilient Supply Chains
Client expense: — · Firm income: $30,000
Matched citations: S. 257
To transfer the functions, duties, responsibilities, assets, liabilities, orders, determinations, rules, regulations, permits, grants, loans, contracts, agreements, certificates, licenses, and privileges of the United States Agency for International Development relating to implementing and administering the Food for Peace Act to the Department of Agriculture.
2026 · third_quarter · Client: LIBERTY MARITIME CORPORATION
Promotion of food aid and cargo preference (S.525, H.R.1207) and national defense sealift (SHIPS for America Act, NDAA), Section 301 tariffs revisions, and national agriculture legislation.
Client expense: — · Firm income: $45,000
Matched citations: H.R.1207
A bill to transfer the functions, duties, responsibilities, assets, liabilities, orders, determinations, rules, regulations, permits, grants, loans, contracts, agreements, certificates, licenses, and privileges of the United States Agency for International Development relating to implementing and administering the Food for Peace Act to the Department of Agriculture.
2026 · third_quarter · Client: LIBERTY MARITIME CORPORATION
Promotion of food aid and cargo preference (S.525, H.R.1207) and national defense sealift (SHIPS for America Act, NDAA), Section 301 tariffs revisions, and national agriculture legislation.
Client expense: — · Firm income: $45,000
Matched citations: S.525
Honey Integrity Act
2026 · third_quarter · Client: AMERICAN HONEY PRODUCERS ASSOCIATION
Lobby to introduce and pass the Honey Integrity Act (H.R. 2162, S. 1028). Lobby FDA to work on enforcement against economically motivated adulteration of honey and to establish a national standard of identity for honey.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2162
Honey Integrity Act
2026 · third_quarter · Client: AMERICAN HONEY PRODUCERS ASSOCIATION
Lobby to introduce and pass the Honey Integrity Act (H.R. 2162, S. 1028). Lobby FDA to work on enforcement against economically motivated adulteration of honey and to establish a national standard of identity for honey.
Client expense: — · Firm income: $60,000
Matched citations: S. 1028
Credit Card Competition Act of 2023
2026 · second_quarter · Client: VISA, INC.
General lobbying on issues related to payments and financial services; issues relating to the Credit Card Competition Act; analysis of policy landscape for competition issues generally; monitor crypto market structure vote in the Senate; S.1838/H.R.3881, the Credit Card Competition Act of 2023 and possible amendments to NDAA
Client expense: — · Firm income: $30,000
Matched citations: H.R.3881
Source: Senate LDA